[EN] NEW ADDITION SALTS OF ZIPRASIDONE, A PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN THERAPY<br/>[FR] NOUVEAUX SELS D'ADDITION DE ZIPRASIDONE, LEUR PROCÉDÉ DE PRÉPARATION ET LEUR UTILISATION EN THÉRAPIE
申请人:SILVERSTONE PHARMA AG
公开号:WO2012096632A1
公开(公告)日:2012-07-19
The invention discloses new addition salts of ziprasidone, namely sulfamates and N- substituted sulfamates in amorphous and crystal form and in the form of hydrates. The processes for their preparation comprise the reaction of 1 mol of ziprasidone base with 1 mol of sulfamic acids, and the method for the isolation of these salts in solid form. The invention further comprises a process for the preparation of granulate for tabletting and incapsulation, wherein ziprasidone salt finely distributed on an inert carrier is obtained. According to the invention, the new salts of ziprasidone are used for the treatment and prevention of psychotic disorders and diseases.
该发明揭示了氯硫嗪的新加合盐,即氨基磺酸盐和N-取代氨基磺酸盐,以非晶和晶体形式及水合物形式存在。它们的制备过程包括氯硫嗪碱与氨基磺酸的1摩尔反应,以及这些盐固态形式的分离方法。该发明还包括一种用于制备制片和封装颗粒的方法,其中在惰性载体上细分布的氯硫嗪盐被获得。根据该发明,氯硫嗪的新盐用于治疗和预防精神障碍和疾病。